1. Market Research
  2. > Business Services
  3. > Business Outsourcing Market Trends
  4. > 2014-2018 Late Phase Study Trends and Market Outlook

2014-2018 Late Phase Study Trends and Market Outlook

  • October 2014
  • -
  • Industry Standard Research
  • -
  • 73 pages

Staying up-to-date with industry practices and usage patterns in this critical stage of clinical development is essential to making informed decisions regarding your own Late Phase research, regardless of whether you work at a sponsor organization or a service provider.

This report provides an overview of current market dynamics in the Late Phase space as well as an outlook of what our survey respondents, all Late Phase decision-makers at sponsor organizations, envision the marketplace will look like in 2018.

ISR also explores the perceptions and selection of Late Phase service providers. Understanding these dynamics can help both study sponsors and CROs better evaluate their position in the marketplace and prepare for upcoming changes and new trends.

What you will learn in this report:

- 4-year examination of the industry’s Late Phase market dynamics (i.e. study volume, outsourcing spend)
- Average per company spend on Late Phase studies and dollar value of outsourced studies
- Criteria sponsors use to select (and disqualify) clinical service providers
- Study conduct and outsourcing penetration across 18 Late Phase study types
- Sponsor predictions and preferences for future changes in Late Phase studies
- Detailed examination of the decision-making process for Late Phase studies

How you can use this report:

For Sponsors: Evaluate your position in the marketplace and prepare for upcoming changes or new trends. Benchmark your Late Phase outsourcing practices against industry-wide trends to make more informed operational, resourcing, and financial decisions.

For Service Providers: Drive operational and Late Phase sales and marketing strategies by understanding sponsor preferences, most important service provider attributes, and reasons service providers lose bids. Develop strategies based on current trends and Late Phase study volume and outsourcing projections for the next 4 years.

Table Of Contents

2014-2018 Late Phase Study Trends and Market Outlook
Table of Contents

Copyright and Usage Guidelines 6
Introduction 7
Methodology 8
Number of Ratings per Company 9
Major Sections 11
Outsourcing Behaviors, Attitudes, Beliefs, and Intentions 12
Preclinical Leaders, Prompted 13
Proposal Volume 15
Service Provider Usage 17
Service Provider Preference 19
Service Provider Preference after User Experience 20
Service Provider Cost Experience and Perception 21
Summary Table 23
Service Provider Selection Drivers 24
Most Important Service Provider Attributes 25
Service Provider Attributes Gaining Importance 26
Service Provider Performance and Scorecards across Attributes 27
Figure 1 - Staff Characteristics Ratings 29
Figure 2 - Operational Excellence Ratings 30
Figure 3 - Organizational and Finance Ratings 31
Performance Summary by Category 32
Service Provider Loyalty 33
Company Service Quality Profiles 34
Absorption Systems 36
Aptiv Solutions 37
Aptuit 38
BioReliance 39
Charles River Laboratories 40
CiToxLab France 41
Covance 42
EMD Millipore 43
Frontage Laboratories Inc 44
Harlan 45
Huntington Life Sciences 46
MDS Pharma 47
MPI Research 48
Myriad RBM 49
Quotient BioResearch 50
Ricerca 51
WuXi AppTec 52
XenoTech 53
Study Data 54
Preclinical Leaders, Prompted 55
Proposal Volume 56
Most Important Service Provider Attributes 57
Service Provider Attributes Gaining Importance 58
Service Provider Usage 59
Service Provider Preference 61
Best Service Providers at Differentiation 62
Service Provider Cost Experience and Perception - All Respondents 63
Service Provider Cost Experience and Perception 65
Outsourcing Service Trends - Past 12 Months 67
Outsourcing Service Trends - Next 12 Months 68
Service Provider Loyalty 69
Overall Satisfaction with Service Providers 70
Willingness to Recommend Service Providers 71
Likelihood to Use Service Providers Again 72
Service Provider Drill-downs 73
Absorption Systems Use and Satisfaction 73
Absorption Systems Performance against Expectations 74
Accelera Use and Satisfaction 75
Accelera Performance against Expectations 76
Alliance Pharma Use and Satisfaction 77
Alliance Pharma Performance against Expectations 78
Aptiv Solutions Use and Satisfaction 79
Aptiv Solutions Performance against Expectations 80
Aptuit Use and Satisfaction 81
Aptuit Performance against Expectations 82
Avanza Laboratories Use and Satisfaction 83
Avanza Laboratories Performance against Expectations 84
BASi Use and Satisfaction 85
BASi Performance against Expectations 86
BioDuro Use and Satisfaction 87
BioDuro Performance against Expectations 88
BioReliance Use and Satisfaction 89
BioReliance Performance against Expectations 90
BRI Biopharmaceutical Research Inc Use and Satisfaction 91
BRI Biopharmaceutical Research Inc Performance against Expectations 92
Calvert Use and Satisfaction 93
Calvert Performance against Expectations 94
CeeTox Inc Use and Satisfaction 95
CeeTox Inc Performance against Expectations 96
Cellular Technology Limited (CTL) Use and Satisfaction 97
Cellular Technology Limited (CTL) Performance against Expectations 98
Charles River Laboratories Use and Satisfaction 99
Charles River Laboratories Performance against Expectations 100
CiToxLab Use and Satisfaction 101
CiToxLab Performance against Expectations 102
Covance Use and Satisfaction 103
Covance Performance against Expectations 104
EMD Millipore Use and Satisfaction 105
EMD Millipore Performance against Expectations 106
Frontage Laboratories Inc Use and Satisfaction 107
Frontage Laboratories Inc Performance against Expectations 108
Harlan Use and Satisfaction 109
Harlan Performance against Expectations 110
Huntington Life Sciences Use and Satisfaction 111
Huntington Life Sciences Performance against Expectations 112
IITRI Use and Satisfaction 113
IITRI Performance against Expectations 114
Indivumed GmbH Use and Satisfaction 115
Indivumed GmbH Performance against Expectations 116
Maccine Use and Satisfaction 117
Maccine Performance against Expectations 118
MD Biosciences Inc Use and Satisfaction 119
MD Biosciences Inc Against Expectations 120
MDS Pharma Use and Satisfaction 121
MDS Pharma Performance against Expectations 122
MicroConstants Inc Use and Satisfaction 123
MicroConstants Inc Performance against Expectations 124
MPI Research Use and Satisfaction 125
MPI Research Performance against Expectations 126
Myriad RBM Use and Satisfaction 127
Myriad RBM Performance against Expectations 128
Quotient BioResearch Use and Satisfaction 129
Quotient BioResearch Performance against Expectations 130
Ricerca Use and Satisfaction 131
Ricerca Performance against Expectations 132
Sequani Use and Satisfaction 133
Sequani Performance against Expectations 134
Sirius Analytical Inc Use and Satisfaction 135
Sirius Analytical Inc Performance against Expectations 136
SNBL Use and Satisfaction 137
SNBL Performance against Expectations 138
Southern Research Use and Satisfaction 139
Southern Research Performance against Expectations 140
SRI International, Biosciences Division Use and Satisfaction 141
SRI International, Biosciences Division Performance against Expectations 142
Taconic Use and Satisfaction 143
Taconic Performance against Expectations 144
Toxicon Use and Satisfaction 145
Toxicon Performance against Expectations 146
Wil Research Use and Satisfaction 147
Wil Research Performance against Expectations 148
William Harvey Research Ltd Use and Satisfaction 149
William Harvey Research Ltd Performance against Expectations 150
WuXi AppTec Use and Satisfaction 151
WuXi AppTec Performance against Expectations 152
XenoBiotic Laboratories Inc Use and Satisfaction 153
XenoBiotic Laboratories Inc Performance against Expectations 154
XenoTech Use and Satisfaction 155
Xenotech Performance against Expectations 156
Cross-service provider performance 157
Respondent Demographics 168
Company Type 168
Outsourcing Responsibility 169
Job Title 169
Phase Responsibility 170
Involvement in Preclinical Development Process 171
Years in the Industry 172
Location 172
Therapeutic Area 173
About Industry Standard Research 174

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 North American Mobile Enterprise Applications

2016 North American Mobile Enterprise Applications

  • $ 10000
  • Industry report
  • October 2016
  • by Frost & Sullivan

Opportunities within Enterprises The overall research objective was to measure the current use and future decision-making behavior toward mobile enterprise applications, including some specific focus on ...

The Service delivery platforms: worldwide market shares 2015

The Service delivery platforms: worldwide market shares 2015

  • $ 7999
  • Industry report
  • September 2016
  • by Analysys Mason

"CSPs are continuing to react to OTT competition by investing in software to deliver next-generation communication, multi-screen video and other digital services that are enabled by APIs and digital identities." ...

Service delivery platforms: worldwide forecast 2016–2020

Service delivery platforms: worldwide forecast 2016–2020

  • $ 7999
  • Industry report
  • November 2016
  • by Analysys Mason

"Virtualisation of service delivery platforms has begun for next-generation communications and video services and will accelerate after 2017." The worldwide service delivery platforms (SDPs) market is ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.